Canada markets closed

Marvel Biosciences Corp. (MRVL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.10500.0000 (0.00%)
At close: 03:58PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 4.65M
Enterprise Value 4.01M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)12.13
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.77

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-56.25%
S&P500 52-Week Change 3-4.45%
52 Week High 30.3500
52 Week Low 30.0850
50-Day Moving Average 30.0956
200-Day Moving Average 30.1670

Share Statistics

Avg Vol (3 month) 39.4k
Avg Vol (10 day) 3277
Shares Outstanding 544.29M
Implied Shares Outstanding 6N/A
Float 826.08M
% Held by Insiders 137.68%
% Held by Institutions 10.00%
Shares Short (Jul 14, 2022) 4188
Short Ratio (Jul 14, 2022) 40.01
Short % of Float (Jul 14, 2022) 4N/A
Short % of Shares Outstanding (Jul 14, 2022) 40.00%
Shares Short (prior month May 12, 2022) 412.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2021
Most Recent Quarter (mrq)Apr 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-320.90%
Return on Equity (ttm)-3,140.15%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.37M
Net Income Avi to Common (ttm)-4.06M
Diluted EPS (ttm)-0.1480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)643.32k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.16
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-2.31M
Levered Free Cash Flow (ttm)-1.45M